Defining cisplatin eligibility in patients with muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer

Published:2021-01-11 Issue:2 Volume:18 Page:104-114
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Jiang Di Maria^ORCID,Gupta Shilpa,Kitchlu Abhijat^ORCID,Meraz-Munoz Alejandro,North Scott A.,Alimohamed Nimira S.,Blais Normand,Sridhar Srikala S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/s41585-020-00404-6.pdf

Reference110 articles.

1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).

2. Charlton, M. E., Adamo, M. P., Sun, L. & Deorah, S. Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004–2010. Cancer 1, 3815–3825 (2014).

3. Lynch, C. F. & Cohen, M. B. Urinary system. Cancer 75, 316–329 (1995).

4. Scosyrev, E., Noyes, K., Feng, C. & Messing, E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115, 68–74 (2009).

5. Burger, M. et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63, 234–241 (2013).

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis;Clinical Genitourinary Cancer;2024-12

2. Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients;Journal of Personalized Medicine;2024-09-09

3. Deutscher Expertenkonsens zur PD-L1-Testung („programmed cell death ligand 1“) in der perioperativen Systemtherapie des muskelinvasiven Blasenkarzinoms;Die Urologie;2024-08-26

4. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

5. Identification and validation of basement membrane-related genes predicting prognosis and immune infiltration associated with bladder cancer;Medicine;2024-07-19